244 related articles for article (PubMed ID: 33507291)
1. Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death.
Roderick JE; Gallagher KM; Murphy LC; O'Connor KW; Tang K; Zhang B; Brehm MA; Greiner DL; Yu J; Zhu LJ; Green MR; Kelliher MA
Blood; 2021 Jan; 137(4):500-512. PubMed ID: 33507291
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway.
Kolenko V; Rayman P; Roy B; Cathcart MK; O'Shea J; Tubbs R; Rybicki L; Bukowski R; Finke J
Blood; 1999 Apr; 93(7):2308-18. PubMed ID: 10090941
[TBL] [Abstract][Full Text] [Related]
3. Effects of glucocorticoid on signalling by prostaglandin E2 in osteoblast-like cells.
Kozawa O; Tokuda H; Kotoyori J; Oiso Y
Prostaglandins Leukot Essent Fatty Acids; 1993 Nov; 49(5):867-72. PubMed ID: 7508132
[TBL] [Abstract][Full Text] [Related]
4. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia.
Real PJ; Tosello V; Palomero T; Castillo M; Hernando E; de Stanchina E; Sulis ML; Barnes K; Sawai C; Homminga I; Meijerink J; Aifantis I; Basso G; Cordon-Cardo C; Ai W; Ferrando A
Nat Med; 2009 Jan; 15(1):50-8. PubMed ID: 19098907
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of prostaglandin (PG)E2-induced prolactin expression in human T cells: cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calcium- and cyclic adenosine 5'-monophosphate-mediated signaling pathways.
Gerlo S; Verdood P; Gellersen B; Hooghe-Peters EL; Kooijman R
J Immunol; 2004 Nov; 173(10):5952-62. PubMed ID: 15528329
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.
Bongiovanni D; Tosello V; Saccomani V; Dalla Santa S; Amadori A; Zanovello P; Piovan E
Oncogene; 2020 Oct; 39(42):6544-6555. PubMed ID: 32917954
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.
Agnusdei V; Minuzzo S; Frasson C; Grassi A; Axelrod F; Satyal S; Gurney A; Hoey T; Seganfreddo E; Basso G; Valtorta S; Moresco RM; Amadori A; Indraccolo S
Leukemia; 2014 Feb; 28(2):278-88. PubMed ID: 23774673
[TBL] [Abstract][Full Text] [Related]
8. JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.
Delgado-Martin C; Meyer LK; Huang BJ; Shimano KA; Zinter MS; Nguyen JV; Smith GA; Taunton J; Winter SS; Roderick JR; Kelliher MA; Horton TM; Wood BL; Teachey DT; Hermiston ML
Leukemia; 2017 Dec; 31(12):2568-2576. PubMed ID: 28484265
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia.
Schwartz JR; Sarvaiya PJ; Vedeckis WV
Mol Cell Endocrinol; 2010 May; 320(1-2):76-86. PubMed ID: 20170710
[TBL] [Abstract][Full Text] [Related]
10. Regulation of vasopressin messenger RNA levels in the small cell lung carcinoma cell line GLC-8: interactions between glucocorticoids and second messengers.
Verbeeck MA; Sutanto W; Burbach JP
Mol Endocrinol; 1991 Jun; 5(6):795-801. PubMed ID: 1717834
[TBL] [Abstract][Full Text] [Related]
11. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
Lauten M; Cario G; Asgedom G; Welte K; Schrappe M
Haematologica; 2003 Nov; 88(11):1253-8. PubMed ID: 14607754
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.
Sokolowska M; Chen LY; Liu Y; Martinez-Anton A; Qi HY; Logun C; Alsaaty S; Park YH; Kastner DL; Chae JJ; Shelhamer JH
J Immunol; 2015 Jun; 194(11):5472-5487. PubMed ID: 25917098
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2--mediated relaxation of the ductus arteriosus: effects of gestational age on g protein-coupled receptor expression, signaling, and vasomotor control.
Waleh N; Kajino H; Marrache AM; Ginzinger D; Roman C; Seidner SR; Moss TJ; Fouron JC; Vazquez-Tello A; Chemtob S; Clyman RI
Circulation; 2004 Oct; 110(16):2326-32. PubMed ID: 15477420
[TBL] [Abstract][Full Text] [Related]
14. Effect of hypoxia on proliferation and glucocorticoid resistance of T-cell acute lymphoblastic leukaemia.
Li Y; Wei Y; Gu L
Hematology; 2021 Dec; 26(1):775-784. PubMed ID: 34565306
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination.
Elliott L; Brooks W; Roszman T
Cell Mol Neurobiol; 1992 Oct; 12(5):411-27. PubMed ID: 1334806
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression.
Cialfi S; Palermo R; Manca S; Checquolo S; Bellavia D; Pelullo M; Quaranta R; Dominici C; Gulino A; Screpanti I; Talora C
Leukemia; 2013 Feb; 27(2):485-8. PubMed ID: 22846929
[No Abstract] [Full Text] [Related]
17. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
[TBL] [Abstract][Full Text] [Related]
18. ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia.
Gallagher KM; Roderick JE; Tan SH; Tan TK; Murphy L; Yu J; Li R; O'Connor KW; Zhu J; Green MR; Sanda T; Kelliher MA
Blood Adv; 2020 Jul; 4(13):3154-3168. PubMed ID: 32658986
[TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis.
Gausdal G; Wergeland A; Skavland J; Nguyen E; Pendino F; Rouhee N; McCormack E; Herfindal L; Kleppe R; Havemann U; Schwede F; Bruserud O; Gjertsen BT; Lanotte M; Ségal-Bendirdjian E; Døskeland SO
Cell Death Dis; 2013 Feb; 4(2):e516. PubMed ID: 23449452
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.
Hall CP; Reynolds CP; Kang MH
Clin Cancer Res; 2016 Feb; 22(3):621-32. PubMed ID: 26080839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
